These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Incidence of adverse effects following metrizamide myelography in nonambulatory and ambulatory patients. Sykes RH; Wasenaar W; Clark P Radiology; 1981 Mar; 138(3):625-7. PubMed ID: 7465839 [TBL] [Abstract][Full Text] [Related]
23. Metrizamide myelography and epidural venography. Their role in the diagnosis of lumbar disc herniation and spinal stenosis. Herkowitz HN; Wiesel SW; Booth RE; Rothman RH Spine (Phila Pa 1976); 1982; 7(1):55-64. PubMed ID: 7071662 [TBL] [Abstract][Full Text] [Related]
24. Prevention of adverse reactions to Amipaque in cervical myelography. Report of a homogeneous series of 380 patients. Legré J; Lavieille J; Debaène A; Tapias PL; Vaillant J J Neuroradiol; 1981; 8(4):353-61. PubMed ID: 6799618 [No Abstract] [Full Text] [Related]
25. [Xeroradiography for cervical myelography using metrizamide (amipaque) (author's transl)]. Schmidt RC; Brase A; Vogelsang H Rontgenblatter; 1978 Jan; 31(1):1-6. PubMed ID: 622525 [TBL] [Abstract][Full Text] [Related]
29. Accidental introduction of contrast medium into the cervical spinal cord. A case report. Servo A; Laasonen EM Neuroradiology; 1985; 27(1):80-2. PubMed ID: 3974870 [TBL] [Abstract][Full Text] [Related]
30. Cervical myelography with a new resorbable contrast medium: Amipaque. Gonsette RE Acta Neurol Belg; 1976; 76(5-6):283-5. PubMed ID: 1007892 [TBL] [Abstract][Full Text] [Related]
31. [[Amipaque contrast medium used in neuroradiology (author's transl)]. Sadowski Z; Tillmann U; Wójcik Z; Chrzanowski R Pol Przegl Radiol Med Nukl; 1980; 44(5):371-5. PubMed ID: 6973149 [No Abstract] [Full Text] [Related]